Connect your AI

Evommune EVMN Issuance Of Common Stock For Convertible Debenture

Issuance Of Common Stock For Convertible Debenture at other companies

Opendoor Technologies IncOPEN

$296M—

Oscar HealthOSCR

$70.83M—

Applied DigitalAPLD

$0—

Ondas, Inc. ONDS

$439.58K-96.4%

Ondas, Inc. ONDS

$46.37K+101%

Lithium AmericasLAC

$53.8M—

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:IssuanceOfCommonStockForConvertibleDebenture.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's issuance of common stock for convertible debenture.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's issuance of common stock for convertible debenture?: Evommune (EVMN) reported issuance of common stock for convertible debenture of $30.58K in Q4 2025.
What does issuance of common stock for convertible debenture mean?: The value of common stock issued upon the conversion of convertible debentures into equity. This reflects the deleveraging process where debt obligations are settled through the issuance of shares.